Violence Against WomenNCT06353425
Multi-country Survey on Violence Against Women Among Women
An observational study of Violence Against Women, run by Chulalongkorn University.
Trial summary
The goal of this observational study is to explore and learn about violence against women (VAW) among reproductive-aged women in Asia and Oceania countries. The main questions it aims to answer are: pattern and prevalence of VAW among reproductive-aged women knowledge, attitude, and practice (KAP) towards VAW among… Read more about this study
- Who is it for?
- Ages 15 to 49 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Violence Against Women
- How many people
- 2,000 participants
- Where
- No sites listed yet
- Study dates
- Apr 2024to Mar 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 49 years
- Women only
- Healthy volunteers accepted
- Child, Adult
Study population: Women in Asia and Oceania countries, who register at the Obstetrics and Gynecology Outpatient Department or Women Health Unit. Participant's biological sex should be female.
Who may be able to join
- ever-partnered women
- aged 15-49 years
- The definition of "ever-partnered women" included women who have current and former husbands; current and former cohabiting; or non-cohabiting male intimate partners.
Who cannot join
- declined to participate
- dropped out midway
Trial locations and contacts
No sites are listed yet.
About this study
Official title: Multi-country Survey on Violence Against Women Among Reproductive-aged Women
The goal of this observational study is to explore and learn about violence against women (VAW) among reproductive-aged women in Asia and Oceania countries. The main questions it aims to answer are:
- pattern and prevalence of VAW among reproductive-aged women
- knowledge, attitude, and practice (KAP) towards VAW among reproductive-aged women
- the need of support services for VAW among reproductive-aged women
Participants will be ever-partnered women aged 15-49 years. The definition of "ever-partnered women" included women who have current and former husbands; current and former cohabiting; or non-cohabiting male intimate partners.
Read the detailed description
Violence against women (VAW) is a global issue that threatens women's physical and emotional wellbeing, and impacts women worldwide, regardless of age, race, ethnicity, or nationality. This survey aims to investigate 1) the pattern and prevalence of VAW among reproductive-aged women; 2) the knowledge, attitude, and practice (KAP) towards VAW among reproductive-aged women; and 3) the need of support services for VAW among reproductive-aged women.
This multinational, hospital-based, cross-sectional study will be carried out in Asia and Oceania countries. We will select the Obstetrics and Gynecology Outpatient Department or Women Health Unit in each nation. Minimum of 400 female citizen in each country will be recruited if they are aged 15-49 years, ever-partnered women, and agree to finish the questionnaire.
The questionnaire, developed in English with inputs from literature and experts, comprises four sections: 1) basic participant characteristics, 2) patterns and prevalence of violence, 3) knowledge, attitudes, and practices towards violence, and 4) the need for support services. A pilot study will validate and translate the questionnaire into the target languages, ensuring content relevance and sensitivity to the target culture through forward and backward translation processes. The reliability of the questionnaire will be assessed using Cronbach's alpha.
Data collection involves preparatory steps such as developing a training manual for interviewers, addressing potential issues, and advertising the survey. Central investigators will monitor the data collection process, with data collected through self-administered questionnaires. The use of REDCap software aims to manage surveys efficiently and prevent multiple participations. A paper-based questionnaire could be used in some areas when necessary.
- Conditions
- Violence Against Women
- Keywords
- reproductive-aged women, violence against women, gender-based violence, knowledge, attitude, practice
- Medical subject headings
- Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Reproductive aged women | Reproductive aged women in Asia and Oceania countries |
What is being measured
The primary outcome is the main question the study is designed to answer.
prevalence of violence against women
using questionnaire to explore the prevalence of various forms of violence against women
Measured: through study completion, an average of 1 year
KAP towards violence against women
using questionnaire to explore knowledge, attitude, and practice towards violence against women
Measured: through study completion, an average of 1 year
Secondary outcomes (1)
need of support services for violence against women
using questionnaire to identify the need of support services for violence against women among reproductive-aged women
Measured: through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Apr 2024
- Study startApr 2024 (estimated)
- Primary completionMar 2025 (estimated)
- Study completionMar 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Violence Against WomenStudies of the same condition, open and under way.
- More trials run by Chulalongkorn UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 2,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Chulalongkorn University
- Sponsor type
- University, hospital or other
- Collaborators
- Asia and Oceania Federation of Obstetrics and Gynaecology
- Responsible party
- Principal investigator, Unnop Jaisamrarn, Chulalongkorn University
- Investigators
- Unnop Jaisamrarn, MD,MHS, Principal investigator, Chulalongkorn University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06353425
- Sponsor's protocol ID
- 0562/66
- Status last verified
- Apr 2024
- First submitted
- 19 Mar 2024
- Last updated
- 9 Apr 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Since this will be a multinational survey, we will decide after discussing about this issue with investigators of each country.
Study at a glance
From the registry record, last updated by the sponsor on 9 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Multi-country Survey on Violence Against Women Among Reproductive-aged Women
- ClinicalTrials.gov ID
- NCT06353425
- Acronym / sponsor ID
- 0562/66
- Conditions
- Violence Against Women
- Keywords
- reproductive-aged women, violence against women, gender-based violence, knowledge, attitude, practice
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 2,000 participants (estimated)
- Lead sponsor
- Chulalongkorn UniversityUniversity, hospital or other
- Collaborators
- Asia and Oceania Federation of Obstetrics and Gynaecology
- Study start
- Apr 2024 (estimated)
- Primary completion
- Mar 2025 (estimated)
- Study completion
- Mar 2025 (estimated)
- First posted
- 9 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to explore and learn about violence against women (VAW) among reproductive-aged women in Asia and Oceania countries. The main questions it aims to answer are:
- pattern and prevalence of VAW among reproductive-aged women
- knowledge, attitude, and practice (KAP) towards VAW among reproductive-aged women
- the need of support services for VAW among reproductive-aged women
Participants will be ever-partnered women aged 15-49 years. The definition of "ever-partnered women" included women who have current and former husbands; current and former cohabiting; or non-cohabiting male intimate partners.
Detailed description
Violence against women (VAW) is a global issue that threatens women's physical and emotional wellbeing, and impacts women worldwide, regardless of age, race, ethnicity, or nationality. This survey aims to investigate 1) the pattern and prevalence of VAW among reproductive-aged women; 2) the knowledge, attitude, and practice (KAP) towards VAW among reproductive-aged women; and 3) the need of support services for VAW among reproductive-aged women.
This multinational, hospital-based, cross-sectional study will be carried out in Asia and Oceania countries. We will select the Obstetrics and Gynecology Outpatient Department or Women Health Unit in each nation. Minimum of 400 female citizen in each country will be recruited if they are aged 15-49 years, ever-partnered women, and agree to finish the questionnaire.
The questionnaire, developed in English with inputs from literature and experts, comprises four sections: 1) basic participant characteristics, 2) patterns and prevalence of violence, 3) knowledge, attitudes, and practices towards violence, and 4) the need for support services. A pilot study will validate and translate the questionnaire into the target languages, ensuring content relevance and sensitivity to the target culture through forward and backward translation processes. The reliability of the questionnaire will be assessed using Cronbach's alpha.
Data collection involves preparatory steps such as developing a training manual for interviewers, addressing potential issues, and advertising the survey. Central investigators will monitor the data collection process, with data collected through self-administered questionnaires. The use of REDCap software aims to manage surveys efficiently and prevent multiple participations. A paper-based questionnaire could be used in some areas when necessary.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Reproductive aged women | – | –Reproductive aged women in Asia and Oceania countries |
Who may qualify
- Ages
- 15 to 49 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- Women in Asia and Oceania countries, who register at the Obstetrics and Gynecology Outpatient Department or Women Health Unit. Participant's biological sex should be female.
Key inclusion criteria (3 listed)
- ever-partnered women
- aged 15-49 years
- The definition of "ever-partnered women" included women who have current and former husbands; current and former cohabiting; or non-cohabiting male intimate partners.
Key exclusion criteria (2 listed)
- declined to participate
- dropped out midway
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
prevalence of violence against women
Time frame: through study completion, an average of 1 year
using questionnaire to explore the prevalence of various forms of violence against women
KAP towards violence against women
Time frame: through study completion, an average of 1 year
using questionnaire to explore knowledge, attitude, and practice towards violence against women
1 secondary outcome
need of support services for violence against women
Time frame: through study completion, an average of 1 year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Apr 2024.
- Individual participant dataSharing planned: Undecided. Since this will be a multinational survey, we will decide after discussing about this issue with investigators of each country.
Related trials for Violence Against Women
Active, not recruiting
What Works to Prevent Violence Against Women and Girls in Madagascar
Comprehensive Sexual Education
Not yet recruitingObservational study
Study on Violence Against Vulnerable Women and Optimizing Support Services
Female Genital Mutilation, Woman Abuse
Recruiting
Familia Imara: A Parenting Program to Reduce Family Violence in Tanzania
Intimate Partner Violence (IPV)
Not yet recruitingObservational study
Resilience and Recovery After Intimate Partner Violence - Evaluation of the EMBER-IPV Protocol
Intimate Partner Violence, Intimate Partner Violence Against Women
Enrolling by invitation
Effect of Moulage-Based Performance on Violence Against Women Awareness
Violence Against Women (VAW), Domestic Violence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Unnop Jaisamrarn, MD,MHS principal investigator
Chulalongkorn University
Questions about this trial
What is this clinical trial studying?
An observational study of Violence Against Women, run by Chulalongkorn University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Unnop Jaisamrarn, MD,MHS (66-81-8123737, dr.unnop@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
prevalence of violence against women (time frame: through study completion, an average of 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2024.